← FDA DRUG APPROVALS

FDA ANDA · ANDA217509

BINIMETINIB

Sponsor: TEVA PHARMACEUTICALS USA, INC.

APPLICATION
ANDA217509
TYPE
ANDA
DOSAGE FORM
TABLET
MARKETING STATUS
None (Tentative Approval)

Products

BINIMETINIBNone (Tentative Approval)
BINIMETINIB 15MG · TABLET

Approval history

2024-12-10UNKNOWN · Original · standardLetterTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →